Loading live market data…

Picard Medical, Inc.

AMEX:PMI

$0.14 USD

$0.0 (-1.75%)

Volume
382.53M
Average Volume
29.47M
Market Capitalization
$218.4M
P/E Ratio
-0.31
Dividend Yield
0.00%
Price Target
$
Year High
$13.68
Year Low
$0.11
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$0.75
Source Headline
Picard Medical / SynCardia Releases Annual Stockholder Presentation Ahead of 2026 Annual Meeting

Presentation Highlights Business Progress, Product Development Milestones, and Matters for Stockholder Consideration Presentation Highlights Business Progress, Product Development Milestones, and Matters for Stockholder Consideration

globenewswire.com - 2026-07-13 08:00:00

Picard Medical / SynCardia Releases Annual Stockholder Presentation Ahead of 2026 Annual Meeting

- Presentation Highlights Business Progress, Product Development Milestones, and Matters for Stockholder Consideration- - Presentation Highlights Business Progress, Product Development Milestones, and Matters for Stockholder Consideration-

globenewswire.com - 2026-07-02 08:00:00

The WSJ Leadership Institute Names Philip Morris International Among “Best Companies For the Future”

Philip Morris International Inc. (PMI) (NYSE: PM) has been named in the WSJ Leadership Institute's inaugural “Best Companies for the Future” ranking, which

gurufocus.com - 2026-06-26 05:00:00

Kuehn Law Encourages Investors of Picard Medical, Inc. to Contact Law Firm

NEW YORK, June 25, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Picard Medical, Inc. (NYSE American: PMI) breached their fiduciary duties to shareholders.

globenewswire.com - 2026-06-25 15:37:00

Perseverance Metals Appoints Isabelle Cadieux as Independent Director

Vancouver, British Columbia--(Newsfile Corp. - June 25, 2026) - Perseverance Metals Inc. (TSXV: PMI) ("Perseverance", "PMI" or the "Company") is pleased to announce that its Board of Directors has appointed Isabelle Cadieux as an Independent Director, effective immediately. Ms. Cadieux, a Professional Geologist in the province of Québec, has over 35 years of experience in mineral exploration and the mining sector in both technical and financial roles, including serving for over 20 years as the Managing Director, Investment at SIDEX - a Québec institutional fund focused on exploration-stage companies in the province.

newsfilecorp.com - 2026-06-25 07:30:00

Picard Medical Announces Leadership Transition

TUCSON, Ariz., June 24, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard Medical” or the “Company”), parent company of SynCardia Systems, LLC (“SynCardia”), maker of the world's first total artificial heart approved by both the U.S. Food and Drug Administration and Health Canada, today announced a leadership transition.

globenewswire.com - 2026-06-24 08:00:00

U.S. Bank Names Eric Levine to Lead Healthcare Payments

MINNEAPOLIS--(BUSINESS WIRE)--Eric Levine has joined U.S. Bank to lead the bank's strategy to deliver more connected treasury, payments and merchant solutions to healthcare organizations. As head of healthcare for Payments: Merchant and Institutional (PMI) Sales Distribution, Levine will advance the company's focus on aligning cross-bank teams to deliver tailored solutions to the healthcare industry, including hospital systems, payers, medical device manufacturers and life sciences companies. L.

businesswire.com - 2026-06-23 09:00:00

WSJ Intelligence Study: Uniquely Human Skills Deemed "Non-Replicable" in Automated Future

STAMFORD, CT--(BUSINESS WIRE)--Philip Morris International (PMI) (NYSE: PM) and WSJ Intelligence, the in-house thought leadership consultancy for The Wall Street Journal's commercial sales organization, today revealed topline findings from a forthcoming study at Journal House during the Cannes Lions International Festival of Creativity. The study delivered a clear takeaway for global businesses: human cognition must be the absolute forefront of the modern corporate landscape. The findings show.

businesswire.com - 2026-06-23 06:00:00

Philip Morris International Announces New Regional Leadership

Philip Morris International (PMI) (NYSE: PM) announced a series of regional leadership appointments that support its ongoing shift toward a smoke‑free future

gurufocus.com - 2026-06-18 05:00:00

Philip Morris International Announces New Regional Leadership

STAMFORD, CT--(BUSINESS WIRE)--Philip Morris International (PMI) (NYSE: PM) announced a series of regional leadership appointments that support its ongoing shift toward a smoke‑free future. Effective August 1, 2026, Marco Hannappel has been appointed President, Europe Region, and Can Kuterdem has been appointed President, Latin America & Canada Region. These appointments build on PMI's evolved organizational model announced in late 2025, under which Gijs de Best serves as President, South A.

businesswire.com - 2026-06-18 04:00:00

Picard Medical and SynCardia to Present New In Vivo Emperor Total Artificial Heart Data and Patient Outcome Research at ASAIO 2026

TUCSON, Ariz., June 16, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard Medical” or the “Company”), parent company of SynCardia Systems, LLC (“SynCardia”), maker of the world's first total artificial heart approved by both the U.S. Food and Drug Administration and Health Canada, today announced that SynCardia researchers will present new preclinical data from the Company's next generation Emperor Total Artificial Heart program and new clinical outcomes research involving patients supported with the SynCardia Total Artificial Heart at the American Society for Artificial Internal Organs (ASAIO) 2026 Annual Conference, taking place June 18-21, 2026, in New Orleans, Louisiana.

globenewswire.com - 2026-06-16 08:00:00

Kuehn Law Encourages Investors of Picard Medical Inc. to Contact Law Firm

NEW YORK, June 9, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Picard Medical Inc. (NYSE AMERICAN: PMI) breached their fiduciary duties to shareholders.  According to a federal securities lawsuit, Insiders at Picard Medical caused the company to misrepresent or fail to disclose that (1) Picard was the subject of a fraudulent stock promotion scheme involving social media-based misinformation and impersonated financial professionals; (2) that insiders and/or affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign; and (3) Picard's public statements and risk disclosures omitted any mention of the false rumors and artificial trading activity driving the stock price.

prnewswire.com - 2026-06-09 19:23:00

Kuehn Law Encourages Investors of Picard Medical Inc. to Contact Law Firm

NEW YORK, June 04, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Picard Medical Inc. (NYSE American: PMI) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at Picard Medical caused the company to misrepresent or fail to disclose that (1) Picard was the subject of a fraudulent stock promotion scheme involving social media-based misinformation and impersonated financial professionals; (2) that insiders and/or affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign; and (3) Picard's public statements and risk disclosures omitted any mention of the false rumors and artificial trading activity driving the stock price.

globenewswire.com - 2026-06-04 13:58:11

Kuehn Law Encourages Investors of Picard Medical Inc. to Contact Law Firm

NEW YORK, June 04, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Picard Medical Inc. (NYSE American: PMI) breached their fiduciary duties to shareholders.

globenewswire.com - 2026-06-04 13:58:00

Kuehn Law Encourages Investors of Picard Medical Inc. to Contact Law Firm

New York, New York--(Newsfile Corp. - June 3, 2026) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Picard Medical Inc. (NYSE American: PMI) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at Picard Medical caused the company to misrepresent or fail to disclose that (1) Picard was the subject of a fraudulent stock promotion scheme involving social media-based misinformation and impersonated financial professionals; (2) that insiders and/or affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign; and (3) Picard's public statements and risk disclosures omitted any mention of the false rumors and artificial trading activity driving the stock price.

newsfilecorp.com - 2026-06-03 11:01:47

Counterfeit Cigarettes Drive EU Illicit Market Above 10% for First Time Since 2014

A new study detailing the scale of the illicit cigarette trade in the European Union (EU) shows that consumption of black-market cigarettes rose more than 7% y

gurufocus.com - 2026-06-03 04:00:00

Artificial Heart Maker Picard Medical's Stock Surges 15% After Hours: Here's What's Going On With PMI

Picard Medical shares surged 15% after hours after reporting successful in vivo studies of its Emperor Total Artificial Heart platform.

feeds.benzinga.com - 2026-06-03 03:50:24

Picard Medical / SynCardia Advances Emperor Total Artificial Heart Program with Successful Next-Generation Preclinical Implant Studies

— Independent dual motor ventricular design demonstrates stable full circulatory support across all study procedures —

globenewswire.com - 2026-06-02 07:00:00

Philip Morris International Participates in 2026 dbAccess Global Consumer Conference; Updates 2026 Full-Year Diluted EPS Forecast for Currency and Non-Cash Impairment Only

Regulatory News: Philip Morris International Inc.'s (PMI) (NYSE: PM) Group CEO PMI, Jacek Olczak, will address investors today at the 2026 dbAccess Global Co

gurufocus.com - 2026-06-02 02:00:00

PICARD MEDICAL, INC. Issues Letter to Shareholders

TUCSON, Ariz., May 29, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (the “Company” or “Picard Medical”), parent company of SynCardia Systems LLC, maker of the world's first and only total artificial heart approved by both the U.S. FDA and Health Canada, today issued the following letter to shareholders:

globenewswire.com - 2026-05-29 07:00:00

IQOS One of the Most Valuable Global Brands, According to Kantar's BrandZ 2026 Ranking

Philip Morris International's (PMI) (NYSE: PM) IQOS, the #1 tobacco heating system1, has been listed for the first time as one of the top 100 most valuable bra

gurufocus.com - 2026-05-26 05:00:00

Picard Medical / SynCardia Reports First Quarter 2026 Financial Results

– Gross profit turns positive; Company executes significant debt reduction – -- Responds to NYSE American continued listing notice - TUCSON, Ariz., May 21, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard Medical” or the “Company”), parent company of SynCardia Systems, LLC, (“SynCardia”) maker of the world's first total artificial heart approved by both the U.S. FDA and Health Canada, reported financial results for the first quarter ended March 31, 2026.

globenewswire.com - 2026-05-21 07:00:00

Picard Medical Announces Pricing of $5 Million Offering

TUCSON, Ariz., May 05, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (the “Company”), parent company of SynCardia Systems, LLC, maker of the world's first total artificial heart approved by both the U.S. FDA and Health Canada, today announced the pricing of its "reasonable best efforts" offering with certain new and existing institutional investors for the purchase and sale of (i) 16,666,667 shares of the Company's common stock, par value $0.0001 per share (or common stock equivalents in lieu thereof) (the “Common Stock”), (ii) series A common warrants to purchase up to 16,666,667 shares of Common Stock (the “Series A Common Warrants”), and (iii) series B common warrants to purchase up to 16,666,667 shares of Common Stock (the “Series B Common Warrants” together with the Series A Common Warrants, the “Common Warrants”) (the “Offering”).

globenewswire.com - 2026-05-05 08:00:00

Picard Medical / SynCardia Recognizes Banner Health as Global Leader and Supporter in the Advancement of Total Artificial Heart Technology

Banner Health has performed more than 50 SynCardia Total Artificial Heart implants, establishing itself as a leading center in total artificial heart therapy Banner Health has performed more than 50 SynCardia Total Artificial Heart implants, establishing itself as a leading center in total artificial heart therapy

globenewswire.com - 2026-04-30 08:00:00

Picard Medical / SynCardia Featured in Interview Series with The Mullings Group

– Discussions to highlight total artificial heart therapy, advanced heart failure market, and next-generation platform development – TUCSON, Ariz., April 29, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard Medical” or the “Company”), parent company of SynCardia Systems LLC (“SynCardia”), maker of the world's first total artificial heart approved by both the U.S. FDA and Health Canada, announced today it has been featured in a two-part interview series with Joe Mullings, Chairman and Chief Executive Officer of The Mullings Group Companies, a premier global executive search firm specialized in the MedTech, HealthTech, and Life Sciences industries.

globenewswire.com - 2026-04-29 08:00:00

Allspring Common Stock Fund: Q1 2026 Top Contributors And Detractors

Health care was the most significant detractor, led by weakness within life sciences tools and services, while consumer discretionary and IT also weighed on relative performance. Regal Rexnord Corp. performed strongly in the first quarter, primarily on account of a quarterly report that featured particularly strong orders owing to budding demand for data center products. Westlake Corp. outperformed in the first quarter due to the effects on global chemical markets from the conflict in Iran, which has had an extreme impact on supply.

seekingalpha.com - 2026-04-20 10:40:00

Picard Medical / SynCardia to Present Next Generation Total Artificial Heart Platform at ISHLT 2026 in Toronto

TUCSON, Ariz., April 16, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard Medical” or the “Company”), parent company of SynCardia Systems, LLC, (“SynCardia”) maker of the world's first total artificial heart approved by both the U.S. FDA and Health Canada, today announced its participation in the International Society for Heart and Lung Transplantation (“ISHLT”) 2026 Annual Meeting, to be held at the Metro Toronto Convention Centre in Toronto, Canada.

globenewswire.com - 2026-04-16 18:56:00

Get PMI Insider Trade Alerts

PMI Price Target Summary

Last Month

$

0 analysts

Last Quarter

$

0 analysts

Last Year

$

0 analysts

All Time

$

0 analysts

PMI Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2026-06-03 HC Wainwright & Co. Maintain Neutral Neutral